Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure.
Vaughan, D E
Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure. [electronic resource] - Circulation Aug 2000 - E43 p. digital
Publication Type: Comment; Letter
1524-4539
10.1161/01.cir.102.6.e43 doi
Angiotensin II--metabolism
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors--therapeutic use
Circadian Rhythm
Drug Interactions
Enalapril--therapeutic use
Fibrinolysis--drug effects
Heart Failure--blood
Humans
Losartan--therapeutic use
Randomized Controlled Trials as Topic
Receptor, Angiotensin, Type 1
Receptor, Angiotensin, Type 2
Renin-Angiotensin System--drug effects
Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure. [electronic resource] - Circulation Aug 2000 - E43 p. digital
Publication Type: Comment; Letter
1524-4539
10.1161/01.cir.102.6.e43 doi
Angiotensin II--metabolism
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors--therapeutic use
Circadian Rhythm
Drug Interactions
Enalapril--therapeutic use
Fibrinolysis--drug effects
Heart Failure--blood
Humans
Losartan--therapeutic use
Randomized Controlled Trials as Topic
Receptor, Angiotensin, Type 1
Receptor, Angiotensin, Type 2
Renin-Angiotensin System--drug effects